Drug Development Stocks List

Drug Development Stocks Recent News

Date Stock Title
May 3 CDXS Codexis, Inc. (NASDAQ:CDXS) Q1 2024 Earnings Call Transcript
May 3 AMPH Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
May 3 CDXS Q1 2024 Codexis Inc Earnings Call
May 3 CDXS Codexis Inc (CDXS) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
May 3 CDXS Codexis, Inc. (CDXS) Q1 2024 Earnings Call Transcript
May 2 CDXS Codexis Inc (CDXS) Q1 2024 Earnings: Surpasses Revenue Forecasts with Strategic Advances
May 2 CDXS Codexis GAAP EPS of -$0.16 beats by $0.02, revenue of $17.1M beats by $3.8M
May 2 CDXS Codexis, Inc. 2024 Q1 - Results - Earnings Call Presentation
May 2 CDXS Codexis Reports First Quarter 2024 Financial Results
May 2 ABCL Insider Stock Buying Reaches US$1.61m On AbCellera Biologics
May 2 AMPH Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know
May 1 CDXS Codexis Q1 2024 Earnings Preview
May 1 BLTE Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting
May 1 AZTA Azenta Announces Fiscal 2024 Second Quarter Earnings Conference Call and Webcast
May 1 ABCL AbCellera partners with PE firms to develop antibody drugs, company creation
May 1 ABCL Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
May 1 AMPH Amphastar Pharmaceuticals (AMPH) Reports Next Week: Wall Street Expects Earnings Growth
May 1 ABCL AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies
May 1 CLNN IBN Announces From Lab to Launch Podcast Featuring Clene Inc. CEO Rob Etherington
Apr 30 AMPH Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024
Drug Development

Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes pre-clinical research on microorganisms and animals, filing for regulatory status, such as via the United States Food and Drug Administration for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug.

Browse All Tags